Sana Biotechnology, Inc.SANANASDAQ

Revenue (LTM)

Net Income (LTM)

$-244M

+8.5% YoY

Free Cash Flow

$-145M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-13
Operating Income	-357	-273↑23.6%	-293↓7.5%	-273↑7.0%	-191↑30.0%
Net Income	-356	-269↑24.3%	-283↓5.1%	-267↑5.8%	-244↑8.5%
EBITDA	-346	-257↑25.7%	-269↓4.5%	-255↑4.9%	-178↑30.2%
EPS Diluted	-2.14	-1.43↑33.2%	-1.46↓2.1%	-1.16↑20.5%	-0.96↑17.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	253	177↓30.1%	134↓24.5%	128↓4.5%	72↓43.7%
Total Current Assets	558	444↓20.4%	214↓52.0%	161↓24.7%	149↓7.5%
Total Assets	1,129	823↓27.2%	565↓31.3%	501↓11.4%	417↓16.8%
Total Current Liabilities	99	112↑12.4%	64↓42.2%	45↓29.5%	79↑73.3%
Total Liabilities	401	323↓19.3%	278↓14.1%	251↓9.8%	256↑2.2%
Total Equity	729	499↓31.5%	288↓42.4%	251↓12.9%	161↓35.8%
Total Debt	111	108↓2.4%	104↓3.8%	94↓9.5%	79↓16.3%
Net Debt	-142	-69↑51.8%	-29↑57.1%	-33↓13.4%	7↑121.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-251	-290↓15.5%	-254↑12.6%	-223↑12.0%	-144↑35.5%
Capital Expenditure	-30	-21↑30.1%	-20↑4.0%	-33↓66.9%	-1↑97.2%
Free Cash Flow	-281	-311↓10.7%	-274↑12.0%	-257↑6.2%	-145↑43.6%
Stock-Based Comp	22	38↑71.4%	36↓7.3%	38↑6.0%	25↓32.4%
Net Change in Cash	135	-75↓155.3%	-50↑33.1%	-6↑88.1%	-55↓829.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance